Preview

Meditsinskiy sovet = Medical Council

Advanced search

Role of metabolic glycemic control in programming perinatal risk in gestational diabetes

https://doi.org/10.21518/2079-701X-2019-17-218-225

Abstract

Purpose. Evaluate the effect of metabolic control of gestational diabetes mellitus (GDM) on the perinatal period course and anthropometric parameters of newborns.

Materials and methods. 300 newborns were divided into 4 groups depending on the metabolic control of the mother. Group 1: fasting glycemia <5.1 mmol/L, 1 hour after meals <7.0 mmol/L (n = 50); Group 2: <5.3 mmol/L and <7.8 mmol/L (n = 90); Group 3: > 5.3 mmol/L and> 7.8 mmol/L (n = 46), respectively; Group 4: control (n = 114). The analysis of the perinatal period course was carried out, the anthropometric parameters were estimated according to the tables INTERGROWTH-21st.

Results. Differences in the frequency of obstetric injuries, which risk is associated with «above average» body weight of the newborn (p = 0.04), were found between the GDM group and the control group (38.7 and 12.3%, respectively, p = 0.0000005). The risk of having a baby with «above average» body weight (Group 1/Group 4, OR = 1.9, p = 0.1; Gr. 2/Gr. 4, OR = 2.6, and Gr. 3/Gr. 4, OR = 3.7, p <0.05), the ratio of weight/length (Gr. 1/Gr. 4, OR = 0.9, p = 0.9; Gr. 2/Gr. 4, OR = 3.6, and Gr. 3/Gr. 4, OR = 4.9, p <0.05) and head circumference (G.1/Gr. 4, OR = 1.1, p = 0.6; Gr. 2/Gr. 4, OR = 2.5, and Gr. 3/Gr. 4, OR = 2.9, p <0.05) was higher in Groups 2 and 3 than in Group 4. In the early neonatal period with GDM, hypoglycemia was more common than in the control Group 4. The lowest risk was in Group 1 (Gr. 1/Gr. 4, OR = 4.8; Gr. 2/Gr. 4, OR = 6.7; Gr. 3/Gr. 4, OR = 7.9, р < 0,05).

Conclusions. Group 1 showed the lowest frequency and risk of adverse effects, which meets the control criteria of the Russian consensus.

About the Authors

A. S. Masel
Almazov National Medical Research Centre
Russian Federation

Alisa S. Masel, Pediatric Endocrinologist, a post-graduate student of Chair for Childhood Diseases

Bldg. 2, 21 Kolomyazhskiy prospekt, St. Petersburg, 197341



I. L. Nikitina
Almazov National Medical Research Centre
Russian Federation

Irina L. Nikitina, Dr. of Sci. (Med.), Professor, Pediatric Endocrinologist, Head of Chair for Childhood Diseases, Head of the Research Laboratory of Pediatric Endocrinology

Bldg. 2, 21 Kolomyazhskiy prospekt, St. Petersburg, 197341



D. A. Yablunovskaya
Almazov National Medical Research Centre
Russian Federation

Dar’ya A. Yablunovskaya, Resident Medical Practitioner, Chair for Childhood Diseases

Bldg. 2, 21 Kolomyazhskiy prospekt, St. Petersburg, 197341



V. Kh. Tekueva
Almazov National Medical Research Centre
Russian Federation

Venera Kh. Tekueva, Resident Medical Practitioner, Chair for Childhood Diseases

Bldg. 2, 21 Kolomyazhskiy prospekt, St. Petersburg, 197341



P. V. Popova
Almazov National Medical Research Centre
Russian Federation

Polina V. Popova, Cand. of Sci. (Med.), Endocrinologist, Head of Research Laboratory of Endocrine Disorders in Pregnancy

Bldg. 2, 21 Kolomyazhskiy prospekt, St. Petersburg, 197341



E. V. Kaprior
Almazov National Medical Research Centre
Russian Federation

Ekaterina V. Kaprior, Resident Medical Practitioner, Chair for Childhood Diseases

Bldg. 2, 21 Kolomyazhskiy prospekt, St. Petersburg, 197341



A. S. Tkachuk
Almazov National Medical Research Centre
Russian Federation

Aleksandra S. Tkachuk, Endocrinologist, a post-graduate student of Chair for Internal Diseases

Bldg. 2, 21 Kolomyazhskiy prospekt, St. Petersburg, 197341



Y. A. Bolotko
Almazov National Medical Research Centre
Russian Federation

Yana A. Bolot’ko, Endocrinologist, a post-graduate student of Chair for Internal Diseases

Bldg. 2, 21 Kolomyazhskiy prospekt, St. Petersburg, 197341



References

1. Hales C.N., Barker D.J. Type 2 (non-insulindependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia. 1992;(35):595–601. Available at: https://link.springer.com/content/pdf/10.1007%2FBF00400248.pdf.

2. Masel A.S., Sabirova EH.M., Kaprior E.V., Nikitina I.L.. The evolution of perceptions of gestational diabetes mellitus (review). Pediatria = Pediatrics (Addendum to Journal of Consilium Medicum). 2018;(3):85–91. (In Russ) Available at: http://pediatria.orscience.ru/archive/2018/evolyutsiyapredstavleniy-o-gestatsionnom-sakharnomdiabeteobzor_3624/?element.

3. Miroshnik E.V., Ryumina I.I., Zubkov V.V. The effect of maternal diabetes on the health of the newborn. Akusherstvo i ginekologiya = Obstetrics and gynecology. 2016;(9):45-49. (In Russ) doi: 10.18565/aig.2016.9.45-9.

4. Dedov I.I., Krasnopol;skiy V.I., Sukhikh G.T. Russian National Consensus Gestational Diabetes: Diagnosis, Treatment, Postpartum Monitoring. Consilium Medicum. 2013;(4):5-9. Available at: https://con-med.ru/magazines/consilium_medicum/consilium_medicum04-2013/rossiyskiy_natsionalnyy_konsensus_gestatsionnyy_sakharnyy_diabet_diagnostika_lechenie_poslerodovoe_n/.

5. Standards of Medical Care in Diabetes—2017: Summary of Revisions. Diabetes Care. 2017;40(1):4-5. doi: 10.2337/dc17-S003.

6. Blumer I., Hadar E., Hadden D.R., Jonanovic L., Mestman J.H., Murad M.H., Yogev Y. Diabetes and Pregnancy: An endocrine society clinical practice guideline. The journal of clinical endocrinology & Metabolism. 2013;98(11):4227– 4249. Available at: https://academic.oup.com/jcem/article/98/11/4227/2834745.

7. Hod M., Kapur A., Sacks D., Hadar E., Agarwal M., Di Renzo G.C., Cabero Roura L., McIntyre H.D., Morris J.L., Divakar H. The international federation of gynecology and obstetrics (FIGO). Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(3):173-211. doi: 10.1016/S00207292(15)30033-3.

8. Bartakova V., Maluškova D., Mužik J., Belobradkova J., Kankova K. Possibility to predict early postpartum glucose abnormality following gestational diabetes mellitus based on the results of routine mid-gestational screening. Biochemia Medica. 2015;25(3):460–468. doi: 10.11613/BM.2015.047.

9. Torres-Espinola F.J., Berglund S.K., GarciaValdes L.M., Segura T., Jerez A., Campos D., Moreno-Torres R., Rueda R., Catena A., PerezGarcia M., Campoy C. Maternal Obesity, overweight and gestational diabetes affect the offspring neurodevelopment at 6 and 18 months of age – A follow up from the PREOBE Cohort. PloSOne. 2015;10(7):e0133010. doi: 10.1371/journal.pone.0133010.

10. Grunnet L.G., Hansen S., Hjort L., Madsen C.M., Kampmann F.B., Thuesen A.C.B., Granstromi C., Strom M., Maslova E., Frikke-Schmidt R., Damm P., Chavarro J.E., Hu F.B., Olsen S.F., Vaag A. Adiposity, dysmetabolic traits, and earlier onset of female puberty in adolescent offspring of women with gestational dabetes mellitus: A clinical study within the Danish national birth cohort. Diabetes Care. 2017;40(12):1746-1755. doi: 10.2337/dc17-0514.

11. Scholtens D.M., Kuang A., Lowe L.P., Hamilton J., Lawrence J.M., Lebenthal Y., Brickman W.J., Clayton P., Ma R.C., McCance D., Tam W.H., Catalano P.M., Linder B., Dyer A.R., Lowe W.L. Jr., Metzger B.E. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 2019;42(3):382-391. doi: 10.2337/dc18-2021.

12. Tam W.H., Ma R.C.W., Ozaki R., Li A.M., Chan M.H.M., Yuen L.Y., Lao T.T.H., Yang X., Ho C.S., Tutino G.E., Chan J.C.N. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 2017;40(5):679–686. doi: 10.2337/dc16-2397.

13. Villar J., Cheikh L.I., Victora C.G., Ohuma E.O., Bertino E., Altman D.G., Lambert A., Papageorghiou A.T., Carvalho M., Jaffer Y.A., Gravett M.G., Purwar M., Frederick I.O., Noble A.J., Pang R., Barros F.C., Chumlea C., Bhutta Z.A., Kennedy S.H. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH21st Project. Lancet. 2014;(384):857–868. doi: 10.1016/S0140-6736(14)60932-6.

14. Ng S.K., Olog A., Spinks A.B., Cameron C.M., Searle J., McClure R.J. Risk factors and obstetric complications of large for gestational age births with adjustments for community effects: Results from a new cohort study. BMC Public Health. 2010;(460):10. doi: 10.1186/1471-245810-460.


Review

For citations:


Masel AS, Nikitina IL, Yablunovskaya DA, Tekueva VK, Popova PV, Kaprior EV, Tkachuk AS, Bolotko YA. Role of metabolic glycemic control in programming perinatal risk in gestational diabetes. Meditsinskiy sovet = Medical Council. 2019;(17):218-225. (In Russ.) https://doi.org/10.21518/2079-701X-2019-17-218-225

Views: 767


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)